We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your email, you agree to the Privacy ...

EVX-01 is designed with Evaxion’s AI-Immunology™ platform and tailored to target the unique tumor profile and immune ...

THE COURT of Tax Appeals (CTA) has ordered the Bureau of Internal Revenue (BIR) to refund P14.59 million to the local branch of United States-based pharmaceutical company Merck Sharp & Dohme (MSD), ...

The American Chamber of Commerce in Vietnam (AmCham Vietnam) on Friday announced Dr. Dam Thi Hoang Lan, external affairs director at MSD Vietnam, as its new chair for the 2025 term. The new chair ...

Merck's stock had a mixed year in 2024, with prices ranging from a low of $94.48 in November to a high of $134.63 in June — a ...

The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products ...

Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study Adults with stage IB-IIIA (American Joint Committee on Cancer seventh edition) resectable NSCLC ...

Patents for blockbuster drugs like semaglutide (sold under brand name Ozempic and Wegovy by Novo Nordisk) and Merck's cancer drug Keytruda are set to expire in the next five years, opening new ...

The new marketing authorization was granted on December 27 to Merck (MRK) Sharp & Dohme Limited. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.

Merck Sharp & Dohme LLC has patented new 5,6 saturated bicyclic heterocyles acting as NLRP3 inflammasome inhibitors potentially useful for the treatment of atherosclerosis, metabolic ...